Sep 21, 2022 7:00 am EDT Castle Biosciences Presents Clinical Use Scenarios for Its Diagnostic Gene Expression Profile Tests at Maui Derm NP+PA Fall 2022 Conference
Sep 20, 2022 4:05 pm EDT Castle Biosciences Presents Foundational Guideposts and Three-Year Financial Targets at 2022 Investor Day
Sep 13, 2022 7:00 am EDT Castle Biosciences Honored with a 2022 AZBio Fast Lane Award from the Arizona Bioindustry Association
Aug 4, 2022 7:00 am EDT American Gastroenterological Association (AGA) Clinical Practice Update States That TissueCypher® May Be Beneficial for Risk-Stratification of Patients with Non-Dysplastic Barrett’s Esophagus
Aug 3, 2022 7:00 am EDT Castle Biosciences to Present at the Canaccord Genuity 42nd Annual Growth Conference
Jul 25, 2022 5:00 pm EDT Castle Biosciences to Release Second Quarter 2022 Financial Results and Host Conference Call on Monday, August 8
Jul 25, 2022 7:00 am EDT DecisionDx®-Melanoma Ordered More Than 100,000 Times for Patients Diagnosed with Cutaneous Melanoma
